ima recommends TeamBrain

We proceeded in several stages with first of all a test of the tool in the middle of the summer season which kept its promises in terms of ultra simple operational implementation. Then we wanted to test the resistance to scalability on a large population, which did not destabilize the device. We were advised for the organization of the treatment teams (experts and administration). Finally after an ROI study we decided to extend the exploitation on 2022 on the entire user population (about 2000). The device is simple to implement and deployment is fast. The scalability reveals a good resistance of the device. The support of the team is reassuring and the results are immediate. The tool is already very satisfactory by its simplicity of use and operation. There are great prospects for tailor-made developments, since the team remains attentive to the needs of the customer.